VICC Seminar Series
Vanderbilt-Ingram Cancer Center sponsors a very active Seminar Program including endowed lectures and minisymposia held throughout the year. Each academic year there is an Orrin Ingram Distinguished Lectureship series featuring 4 to 5 distinguished extramural investigators who present research discoveries that has been seminal to major advances in cancer diagnosis, prevention, treatment, and contribute to our understanding of the mechanisms of tumorigenesis.
The VICC Seminar Series is held on Thursdays throughout the academic year.
View upcoming VICC Seminars
Watch past lectures
Fall 2016 - Spring 2017
SWI/SNF (BAF) Chromatin Remodeling Complexes are Frequently Mutated in Cancer: Mechanisms and Vulnerabilities (Mar. 9, 2017)
Charles M. Roberts, M.D.
Cancer Center Director and EVP
St. Jude Children’s Research Hospital
Population and Tumor Heterogeneity in Cancer Genome Scienceand Precision Oncology (Feb. 23, 2017)
John D. Carpten, Ph.D.
Professor, Department of Urology; Chair, Department of Translational Genomics; Director, USC Institute of Translational Genomics
USC Keck School of Medicine
For better or for worse: Immune modulation of pancreatic cancer (Dec. 15, 2016)
Steven D. Leach, M.D.
David M. Rubenstein Chair and Director, Rubenstein Center for Pancreatic Cancer Research
Memorial Sloan Kettering Cancer Center, New York, NY
Lymphoplegia in cancer treatment: The role of HMGB1 and mitochondria in tumor infiltrating lymphocytes (Oct.3, 2016)
Michael T. Lotze, M.D.
Professor of Surgery, Immunology, and Bioengineering; Assistant Vice Chancellor
University of Pittsburgh Schools of the Health Sciences
Triumphs and Challenges in Treating Metastatic Melanoma (Sept. 29, 2016) - Video not available
Harriet Kluger, M.D.
Professor of Medicine and Medical Oncology
Psychosocial Oncology Care: Variations on a Complex Theme (Sept. 15, 2016)
Donald Rosenstein, M.D.
Professor, Department of Psychiatry and Medicine; Director, Comprehensive Cancer Support Program
University of North Carolina, Chapel Hill, SC
Fall 2015 - Spring 2016
Risk Models and Cancer Prevention (May 12, 2016)
Mitch Gail, M.D., Ph.D.
Senior Investigator, National Cancer Institute Division of Cancer Epidemiology and Genetics, Biostatistics Branch
Molecular Control of Metastatic Progression (April 28, 2016)
Sohail Tavazoie, M.D., Ph.D.
Associate Professor; Head, Laboratory of Systems Cancer Biology
The Rockefeller University
Viewing the Immune System Through the Lens of Gene Regulatory Networks (April 21, 2016)
Harinder Singh, Ph.D.
Professor of Pediatrics; Director, Division of Immunology; Director, Center for Systems Immunology
Cincinnati Children's Hospital
Biomarker Accessible and Chemically AddressableSubtypes of Neoplastic Disease (April 14, 2016)
Michael White, Ph.D.
Professor and Grant A. Dove Distinguished Chair for Research in Oncology
UT Southwestern Medical Center, Dallas, TX
Recruitment, Retention, Surgical and Medication Adherence Studies with African Americans: Lessons Learned (March 31, 2016)
Marvella E. Ford, Ph.D.
Professor, Department of Public Health Sciences
Associate Director, Cancer Disparities
Hollings Cancer Center,Medical University of South Carolina, Charleston
Hypoxia, Metabolism, and Tumor Progression (March 29, 2016)
M. Celeste Simon, Ph.D.
Scientific Director and Investigator, Abramson Cancer Research Institute
Professor, Cell and Developmental Biology
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
MicroDNAs, Histone Chaperones and MCM Homologs: New Windows into Genomic Instability (March 10, 2016)
Anindya Dutta, M.D., Ph.D.
Harry F. Byrd Professor and Chair, Department of Biochemistry & Molecular Genetics
Professor of Pathology
University of Virginia, Charlottesville, VA
Addressing Social Determinants of Cancer Health Disparities Using a Community-Based Participatory Approach(February 25, 2016)
Chanita Hughes-Halbert, Ph.D.
Associate Dean for Assessment and Evaluation, College of Medicine
Professor, Department of Psychiatry and Behavioral Sciences
Endowed Chair for Cancer Equity
Hollings Cancer Center, Medical University of South Carolina
(February 18, 2016) - Video not available
Timothy N. J. Bullock, Ph.D.
Associate Professor of Pathology
University of Virginia School of Medicine
Implementing Lung Cancer Screening: Why Does It Have To Be So Hard?(January 28, 2016)
Michael K. Gould, M.D., M.S.
Director for Health Services Research and Implementation Science
Kaiser Permanente Southern California
Use of Dual-Mode Cellular Imaging in Cancer Vaccine Development(January 21, 2016)
Jeff W.M. Bulte, M.S., Ph.D.
Russell H. Morgan Dept. of Radiology and Radiological Science
Cellular Imaging Section and Vascular Biology Program
Institute for Cell Engineering
The Johns Hopkins University School of Medicine
FoxO regulation and function in aging and development(January 14, 2016)
Patrick J. Hu, M.D., Ph.D.
Associate Professor, Departments of Internal Medicine and Cell & Developmental Biology
University of Michigan
Treating Melanoma with the Immune System(May 7, 2015)
Antoni Ribas, M.D., Ph.D.
Director,Tumor Immunology Program
Jonsson Comprehensive Cancer Center
University of California, Los Angeles